Scarica l'app Stockscreener
23.71
0.81%
0.19
Dopo l'orario di chiusura:
23.71
Precedente Chiudi:
$23.52
Aprire:
$23.32
Volume 24 ore:
2.31M
Relative Volume:
0.76
Capitalizzazione di mercato:
$5.85B
Reddito:
$426.45M
Utile/perdita netta:
$197.67M
Rapporto P/E:
28.91
EPS:
0.82
Flusso di cassa netto:
$110.10M
1 W Prestazione:
-3.26%
1M Prestazione:
+31.65%
6M Prestazione:
+25.92%
1 anno Prestazione:
+248.16%
Intervallo 1D:
$23.30
$24.17
Intervallo di 1 settimana:
$22.43
$24.48
Portata 52W:
$6.72
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Confronta ADMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
23.71 | 5.85B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - Yahoo Finance
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings? - MSN
Adma Biologics (ADMA) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know - MSN
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down - The Globe and Mail
Has ADMA Biologics (ADMA) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Why ADMA Biologics, Inc. (ADMA) Surged on Monday - MSN
The Zacks Analyst Blog Highlights ADMA, FirstCash, Stride, Life Time Group and National Fuel Gas - Yahoo Finance
These 5 Buy-Ranked Mid-Cap Stocks Are Flying High Year to Date - The Globe and Mail
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times
ADMA Biologics Q1 2025 Earnings: Key Financial Updates Coming May 7 for Growing Biopharmaceutical Leader - Stock Titan
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
ADMA Biologics (ADMA) Achieves Key FDA Approval for Production B - GuruFocus
ADMA Biologics (ADMA) Attracts Hedge Fund Attention Amid Takeover Speculation - GuruFocus
ADMA Biologics stock soars to all-time high of $24.02 By Investing.com - Investing.com South Africa
ADMA Biologics (ADMA) Gains FDA Approval for Yield Enhancement P - GuruFocus
Sector Update: Health Care Stocks Swing Between Small Gains, Losses - marketscreener.com
Noteworthy Monday Option Activity: ADMA, MAR, HUM - Nasdaq
Sector Update: Health Care - marketscreener.com
What's Going On With ADMA Stock Monday?ADMA Biologics (NASDAQ:ADMA) - Benzinga
ADMA Biologics stock soars to all-time high of $24.02 - Investing.com
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday - Benzinga
Adma Biologics Announces U.S. Fda Approval of Innovative Production Yield Enhancement Process - marketscreener.com
FDA Approves ADMA Biologics' Innovative Production Yield Enhancement Process - Nasdaq
ADMA Biologics Receives FDA Approval for Innovative Yield Enhancement Process, Paving the Way for Increased Production Capacity and Revenue Growth - Nasdaq
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process - Bluefield Daily Telegraph
ADMA Biologics Achieves Industry First: FDA Green Lights Revolutionary 20% Plasma Yield Enhancement - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
20 Takeover Rumors Hedge Funds Are Buying - Insider Monkey
ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying - MSN
10 Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
Is ADMA Biologics, Inc. (ADMA) the Best Multibagger Stock to Buy According to Billionaires? - Insider Monkey
Adma Biologics (ADMA) Gains But Lags Market: What You Should Know - Yahoo
Why ADMA Biologics Inc. (ADMA) Performed Worst On Monday? - Insider Monkey
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
3.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):